Consumo de sustancias durante un programa de mantenimiento con metadona

  1. I. Iraurgi 1
  2. A. Aizpuru 2
  3. E. Pinilla 3
  4. J. J. Marcos 2
  5. J. Unda 2
  6. B. Ormaetxea 2
  7. A. Casas 1
  8. M. A. Tomás 2
  9. M. A. Torre 2
  10. I. Omagoxeaskoa 2
  1. 1 Módulo Psicosocial de Rekalde
  2. 2 Programa de Objetivos Intermedios (Metadona) de Bizkaia. Osakidetza
  3. 3 Hospital Psiquiátrico de Zamudio
Aldizkaria:
Psiquiatría biológica: Publicación oficial de la Sociedad Española de Psiquiatría Biológica

ISSN: 1134-5934

Argitalpen urtea: 2002

Alea: 9

Zenbakia: 3

Orrialdeak: 109-115

Mota: Artikulua

Beste argitalpen batzuk: Psiquiatría biológica: Publicación oficial de la Sociedad Española de Psiquiatría Biológica

Laburpena

Aim: To examine levels of heroine and cocaine consumption during treatment in a methadone maintenance program (MMP), as well as the factors associated with the use of these substances. Method: A prospective longitudinal study was performed in 376 patients undergoing methadone treatment. The patients' demographic variables, history of addiction and treatment data were recorded. Use of methadone, heroin and cocaine were assessed using twice-weekly urine toxicology screens over a 13-month follow-up. Results and discussion: Moderate use of illicit drugs was found during the methadone treatment. Heroine was used at some time by 72.9%, continuously by 9%, and frequently by 27.4%. Cocaine was consumed at some time by 46.1%, continuously by 10.8%, and frequently by 20.9%. Linear regression analysis revealed cocaine use (β = 0.33) and participation in the MMP (β = 0.10) to be predictive factors of heroin use during methadone maintenance. Similarly, heroin use was the only predictor of cocaine use during MMP (β = 0.33).